QQQ   432.65 (+0.37%)
AAPL   169.88 (-1.63%)
MSFT   417.18 (+0.86%)
META   502.36 (+0.43%)
GOOGL   155.37 (+0.33%)
AMZN   184.05 (+0.23%)
TSLA   156.63 (-3.00%)
NVDA   878.34 (+2.13%)
AMD   163.80 (+2.17%)
NIO   3.88 (-0.26%)
BABA   69.98 (-0.91%)
T   16.05 (-1.17%)
F   12.20 (-0.25%)
MU   121.93 (+0.46%)
GE   156.83 (+2.04%)
CGC   6.84 (-2.01%)
DIS   114.18 (+1.09%)
AMC   2.79 (+12.96%)
PFE   25.85 (-0.23%)
PYPL   63.89 (+0.60%)
XOM   118.94 (-0.62%)
QQQ   432.65 (+0.37%)
AAPL   169.88 (-1.63%)
MSFT   417.18 (+0.86%)
META   502.36 (+0.43%)
GOOGL   155.37 (+0.33%)
AMZN   184.05 (+0.23%)
TSLA   156.63 (-3.00%)
NVDA   878.34 (+2.13%)
AMD   163.80 (+2.17%)
NIO   3.88 (-0.26%)
BABA   69.98 (-0.91%)
T   16.05 (-1.17%)
F   12.20 (-0.25%)
MU   121.93 (+0.46%)
GE   156.83 (+2.04%)
CGC   6.84 (-2.01%)
DIS   114.18 (+1.09%)
AMC   2.79 (+12.96%)
PFE   25.85 (-0.23%)
PYPL   63.89 (+0.60%)
XOM   118.94 (-0.62%)
QQQ   432.65 (+0.37%)
AAPL   169.88 (-1.63%)
MSFT   417.18 (+0.86%)
META   502.36 (+0.43%)
GOOGL   155.37 (+0.33%)
AMZN   184.05 (+0.23%)
TSLA   156.63 (-3.00%)
NVDA   878.34 (+2.13%)
AMD   163.80 (+2.17%)
NIO   3.88 (-0.26%)
BABA   69.98 (-0.91%)
T   16.05 (-1.17%)
F   12.20 (-0.25%)
MU   121.93 (+0.46%)
GE   156.83 (+2.04%)
CGC   6.84 (-2.01%)
DIS   114.18 (+1.09%)
AMC   2.79 (+12.96%)
PFE   25.85 (-0.23%)
PYPL   63.89 (+0.60%)
XOM   118.94 (-0.62%)
QQQ   432.65 (+0.37%)
AAPL   169.88 (-1.63%)
MSFT   417.18 (+0.86%)
META   502.36 (+0.43%)
GOOGL   155.37 (+0.33%)
AMZN   184.05 (+0.23%)
TSLA   156.63 (-3.00%)
NVDA   878.34 (+2.13%)
AMD   163.80 (+2.17%)
NIO   3.88 (-0.26%)
BABA   69.98 (-0.91%)
T   16.05 (-1.17%)
F   12.20 (-0.25%)
MU   121.93 (+0.46%)
GE   156.83 (+2.04%)
CGC   6.84 (-2.01%)
DIS   114.18 (+1.09%)
AMC   2.79 (+12.96%)
PFE   25.85 (-0.23%)
PYPL   63.89 (+0.60%)
XOM   118.94 (-0.62%)
OTCMKTS:DNPUF

Sumitomo Pharma (DNPUF) Stock Price, News & Analysis

$2.40
0.00 (0.00%)
(As of 04/15/2024 ET)
Today's Range
$2.40
$2.40
50-Day Range
$2.27
$2.79
52-Week Range
$2.27
$6.33
Volume
N/A
Average Volume
3,138 shs
Market Capitalization
N/A
P/E Ratio
0.04
Dividend Yield
598.80%
Price Target
N/A
DNPUF stock logo

About Sumitomo Pharma Stock (OTCMKTS:DNPUF)

Sumitomo Pharma Co., Ltd. engages in the manufacture and sale of pharmaceuticals, food ingredients and additives, veterinary medicines, and others in Japan, North America, China, and internationally. The company offers pharmaceutical products, such as therapeutic agents for Parkinson's disease, uterine fibroids, depression, type 2 diabetes, systemic fungal infection, hypertension, pruritus, advanced prostate cancer, overactive bladder, chronic obstructive pulmonary disease, angina pectoris, and arrhythmia. It provides products for atypical antipsychotic, cultured thymus tissue for pediatric congenital athymia, antiepileptic, and carbapenem antibiotic; and Fabry disease drugs. In addition, the company offers food ingredients and additives, such as polysaccharides, as well as seasonings, such as soups or bouillons; and chemical product materials, which include pharmaceutical excipients, personal care products, coatings and industrial materials, and electronic materials. Further, it provides veterinary medicines for companion animals, such as dogs and cats; and livestock comprising cattle, swine, poultry, horses, and aquacultured fish. It has partnerships with Keio University; RIKEN; Kyoto University; and collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company has a strategic alliance with Roivant Sciences Ltd. The company was formerly known as Sumitomo Dainippon Pharma Co., Ltd. and changed its name to Sumitomo Pharma Co., Ltd. in April 2022. The company was incorporated in 1897 and is headquartered in Osaka, Japan. Sumitomo Pharma Co., Ltd. is a subsidiary of Sumitomo Chemical Company, Limited.

DNPUF Stock Price History

DNPUF Stock News Headlines

Your eBook: Mastering Earnings Announcements Trading
Trading around earnings announcements (Pre-Earnings, Into-Earnings, and Post-Earnings) provides a unique trading opportunity. That is because trading around earnings announcements presents short-term trading opportunities (these are great because they don’t tie your money up for very long).
Sumitomo Dainippon Pharma Co Ltd (4506)
Sumitomo Pharma Co Ltd 4506
Your eBook: Mastering Earnings Announcements Trading
Trading around earnings announcements (Pre-Earnings, Into-Earnings, and Post-Earnings) provides a unique trading opportunity. That is because trading around earnings announcements presents short-term trading opportunities (these are great because they don’t tie your money up for very long).
Sumitomo Metal Industries
3 Pharma Stocks That Will Boom Thanks to AI
Sumitomo Pharma Co., Ltd. (DNPUF)
Revisiting Myovant...
Sumitomo Pharma Co Ltd
See More Headlines
Receive DNPUF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sumitomo Pharma and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
OTCMKTS:DNPUF
CIK
N/A
Fax
N/A
Employees
6,250
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

  • Mr. Hiroshi Nomura (Age 67)
    CEO, President & Representative Director
    Comp: $667.31k
  • Mr. Toru Kimura Ph.D. (Age 64)
    Sr. Mngg Exec. Off. of Glo. Crprate Stgy, F&A, Regen & Cell Med. Off., Kobe Ctr, Mfg. Plt and Dir.
  • Mr. Hiroyuki Baba (Age 65)
    Mngg Exec. Officer of Global Data Design, Lgl Affairs. IP, IT Mgt, & Frontier Bus. Off. & Director
  • Mr. Naoki Noguchi
    Executive Officer of Corporate Governance & Communications, VP and Head of Corporate Communications
  • Mr. Takuya Taguchi
    M.E.O. of Sales & Marketing Div., SVP, Hd of Sales & Marketing Div. and Dep. Hd of Japan Bus. Unit
  • Ms. Atsuko Higuchi
    Managing Executive Officer of External Affairs, Corporate Secretariat & Human Resources
  • Mr. Yoshiharu Ikeda Ph.D. (Age 66)
    Managing Executive Officer of Drug Research Division, Head of Japan Business Unit & Director
  • Mr. Koichi Kozuki
    E.O. of R. Aff., Med. Sci., C.R.C. & Q.A., Sr. VP, Hd of C.R.C. & Q.A. Div and Dp. Hd of Japan Bus.
  • Dr. Shigeyuki Nishinaka Ph.D. (Age 60)
    Managing Executive Officer of Business Development & Management and Director
  • Mr. Isao Shimizu
    Executive Officer, Senior VP, Head of Drug Research Division & Senior Executive Research Director

DNPUF Stock Analysis - Frequently Asked Questions

Should I buy or sell Sumitomo Pharma stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sumitomo Pharma in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" DNPUF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in DNPUF, but not buy additional shares or sell existing shares.
View DNPUF analyst ratings
or view top-rated stocks.

How have DNPUF shares performed in 2024?

Sumitomo Pharma's stock was trading at $3.13 on January 1st, 2024. Since then, DNPUF shares have decreased by 23.3% and is now trading at $2.40.
View the best growth stocks for 2024 here
.

Are investors shorting Sumitomo Pharma?

Sumitomo Pharma saw a increase in short interest during the month of February. As of February 29th, there was short interest totaling 10,140,000 shares, an increase of 5.3% from the February 14th total of 9,626,700 shares. Based on an average trading volume of 4,400 shares, the short-interest ratio is currently 2,304.5 days.
View Sumitomo Pharma's Short Interest
.

Is Sumitomo Pharma a good dividend stock?

Sumitomo Pharma (OTCMKTS:DNPUF) pays an annual dividend of $14.37 per share and currently has a dividend yield of 1.27%. The dividend payout ratio is 24.70%. This payout ratio is at a healthy, sustainable level, below 75%.

How do I buy shares of Sumitomo Pharma?

Shares of DNPUF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:DNPUF) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners